Simplex Trading
VERA icon

Simplex Trading’s Vera Therapeutics VERA Stock Holding History

Simplex Trading’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116K Buy
2,700
+2,500
+1,250% +$93.2K ﹤0.01% 5361
2026
Q1 		$8.04K Sell
200
-1,400
-88% -$60.3K ﹤0.01% 7544
2025
Q4 		$81K Sell
1,600
-1,500
-48% -$53.3K ﹤0.01% 5200
2025
Q3 		$90K Sell
3,100
-41,700
-93% -$964K ﹤0.01% 5877
2025
Q2 		$1.05M Buy
44,800
+37,100
+482% +$834K ﹤0.01% 2723
2025
Q1 		$184K Buy
7,700
+100
+1% +$3.21K ﹤0.01% 4440
2024
Q4 		$321K Buy
7,600
+400
+6% +$17.7K ﹤0.01% 3999
2024
Q3 		$318K Buy
7,200
+1,100
+18% +$41.7K ﹤0.01% 4068
2024
Q2 		$220K Sell
6,100
-16,400
-73% -$651K ﹤0.01% 4574
2024
Q1 		$970K Buy
22,500
+22,400
+22,400% +$798K ﹤0.01% 3154
2023
Q4 		$1K Buy
+100
New +$1.27K ﹤0.01% 8604
2023
Q3 		– Sell
-77,400
Closed -$1.24M – 9916
2023
Q2 		$1.24M Buy
77,400
+70,300
+990% +$635K ﹤0.01% 2392
2023
Q1 		$55K Buy
+7,100
New +$54.8K ﹤0.01% 5825

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Simplex Trading's VERA Position: Q2 2026 in Review

Simplex Trading increased its Vera Therapeutics (VERA) stake by 2,364% in Q2 2026, buying an estimated $168K and bringing the position to 4,707 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #4706.

Simplex Trading first reported a position in VERA in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.13M in Q2 2023. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Simplex Trading held 4,707 shares of Vera Therapeutics worth $202K as of Q2 2026.
  • Simplex Trading bought 4,516 Vera Therapeutics shares in Q2 2026, an estimated $168K.
  • Vera Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4706 holding.
  • Simplex Trading first reported a position in Vera Therapeutics in Q1 2023 and has held it in 6 quarters since.
  • Simplex Trading's Vera Therapeutics position peaked at $1.13M in Q2 2023.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.